A risk-based approach to experimental early phase clinical trials during the COVID-19 pandemic.

Tiu, Crescens; Shinde, Rajiv; Yap, Christina; Rao Baikady, Bindumalini; Banerji, Udai; Minchom, Anna R; de Bono, Johann S; Lopez, Juanita S

Tiu, Crescens; Shinde, Rajiv; Yap, Christina; Rao Baikady, Bindumalini; Banerji, Udai; Minchom, Anna R; de Bono, Johann S; Lopez, Juanita S.

Tiu C; Phase I Drug Development Unit, The Royal Marsden Hospital and The Institute of Cancer Research, Sutton, UK.
Shinde R; Phase I Drug Development Unit, The Royal Marsden Hospital and The Institute of Cancer Research, Sutton, UK.
Yap C; Institute of Cancer Research's Clinical Trials and Statistics Unit, Sutton, UK.
Rao Baikady B; Phase I Drug Development Unit, The Royal Marsden Hospital and The Institute of Cancer Research, Sutton, UK.
Banerji U; Phase I Drug Development Unit, The Royal Marsden Hospital and The Institute of Cancer Research, Sutton, UK.
Minchom AR; Phase I Drug Development Unit, The Royal Marsden Hospital and The Institute of Cancer Research, Sutton, UK.
de Bono JS; Phase I Drug Development Unit, The Royal Marsden Hospital and The Institute of Cancer Research, Sutton, UK.
Lopez JS; Phase I Drug Development Unit, The Royal Marsden Hospital and The Institute of Cancer Research, Sutton, UK. Electronic address: Juanita.Lopez@icr.ac.uk.

Lancet Oncol ; 21(7): 889-891, 2020 07.

Article in English | MEDLINE | ID: covidwho-627778

Subject(s)

Clinical Trials, Phase I as Topic; Coronavirus Infections/epidemiology; Neoplasms/drug therapy; Pneumonia, Viral/epidemiology; Antiviral Agents/therapeutic use; Betacoronavirus; COVID-19; Clinical Trials, Phase I as Topic/statistics & numerical data; Coronavirus Infections/prevention & control; Data Management; Humans; Pandemics/prevention & control; Pneumonia, Viral/prevention & control; Risk Assessment; SARS-CoV-2; United Kingdom/epidemiology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Clinical Trials, Phase I as Topic / Coronavirus Infections / Neoplasms Type of study: Observational study / Prognostic study / Randomized controlled trials Limits: Humans Country/Region as subject: Europa Language: English Journal: Lancet Oncol Journal subject: Neoplasms Year: 2020 Document Type: Article Affiliation country: S1470-2045(20)30339-9

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google